R&D spending News
Most Popular R&D spending Story
Fallout from Pfizer-Wyeth deal begins
When any two mega-companies join hands, some suffering will follow. Who stands to lose when Pfizer and Wyeth wrap up their big merger? There's already one casualty: Dutch biotech Crucell. Wyeth had Read more...
Latest Headlines
- December 14, 2011
- April 29, 2011
- November 16, 2010
- August 26, 2009
- July 9, 2009
- January 26, 2009
- January 21, 2009
- October 29, 2008
- October 29, 2008
- October 29, 2008
- October 5, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
